<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="41900">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01958424</url>
  </required_header>
  <id_info>
    <org_study_id>MMC-16092013-CTIL</org_study_id>
    <nct_id>NCT01958424</nct_id>
  </id_info>
  <brief_title>In Vitro Fertilization Outcomes in Metabolic Syndrome</brief_title>
  <official_title>The Influence of Metabolic Syndrome on in Vitro Fertilization Treatment Outcome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meir Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Meir Medical Center</source>
  <oversight_info>
    <authority>Israel: Ethics Commission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine the effect of metabolic syndrome in over-weight
      women on IVF treatment outcomes.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>April 2014</start_date>
  <primary_completion_date type="Anticipated">April 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>success or failure of ivf treatment</measure>
    <time_frame>within 1 year from intiation of ivf treatment</time_frame>
    <safety_issue>No</safety_issue>
    <description>success or failure of a treatment will  be determined by beta-Human chorionic gonadotropin test, number of oocyte retrieved or fertilized and embryos quality.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>blood levels of C-reactive protein</measure>
    <time_frame>within 1 year from initiation of ivf treatment</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>follicle liquid levels of C-reactive protein</measure>
    <time_frame>within 1 year from initiation of ivf treatment</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Metabolic Syndrome</condition>
  <arm_group>
    <arm_group_label>women with metabolic syndrome</arm_group_label>
    <description>women undergoing ivf treatment who have BMI&gt;25 and meet the criteria for metabolic syndrome</description>
  </arm_group>
  <arm_group>
    <arm_group_label>women without metabolic syndrome</arm_group_label>
    <description>women undergoing ivf treatment who have BMI&gt;25 and who do not meet the criteria for metabolic syndrome</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        women undergoing ivf treatment in &quot;Meir&quot; medical center in &quot;Kfar-Saba, Israel
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  women undergoing ivf treatment

        Exclusion Criteria:

          -  inflammatory disease

          -  acute conditions
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amir Waiser, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>&quot;Meir&quot;, Medical centere</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sapir Medical Center, Meir Hospital</name>
      <address>
        <city>Kfar-Saba</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Einat Haikin Herzberger, M.D</last_name>
      <email>einatcha1@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Einat Haikin Herzberger, M.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 9, 2013</lastchanged_date>
  <firstreceived_date>October 6, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>metabolic syndrome</keyword>
  <keyword>in vitro fertilization</keyword>
  <keyword>c reactive protein</keyword>
  <keyword>over-weight women</keyword>
  <keyword>ovarian stimulation</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Metabolic Syndrome X</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
